Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Hypertension 2Prostatic Neoplasms 1Pancreatic Neoplasms 1Melanoma 1Lymphoma, Follicular 1Heart Failure 1Cardiovascular Diseases 1Cardiotoxicity 1

Interventions

relacorilant 5Nutrition Assessment 4Hydrochlorothiazide 4Bevacizumab 3Amlodipine 3aliskiren 2Osilodrostat 2Lisinopril 2Labetalol 2Angiotensin-Converting Enzyme Inhibitors 2Adrenalectomy 2ziprasidone 1sacubitril and valsartan sodium hydrate drug combination 1pembrolizumab 1pazopanib 1lutetium Lu 177 dotatate 1ganirelix 1gallium Ga 68 dotatate 1fimasartan 1enzalutamide 1clevidipine 1cediranib 1bicalutamide 1benazepril 1Zolpidem 1Warfarin 1Vitamin D 1Vecuronium Bromide 1Vancomycin 1Urine Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hypertension × Angiotensin-Converting Enzyme Inhibitors × Clear all
NCT04334824 2024-09-19

Hydrochlorothiazide and Risk of Skin Cancer

Canadian Network for Observational Drug Effect Studies, CNODES

Completed
2,953,748 enrolled
Dermatologic

Hypertension, Melanoma

NCT01258764 2015-05-20

1HAT

Scripps Translational Science Institute

Phase NA Completed
2 enrolled
Lymphoid

Hypertension, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡